Navigation Links
VIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008
Date:9/15/2008

Topline Data from Phase 2 CEA and ACS Clinical Trials to be Released

Concurrent with AHA Presentation

SAN FRANCISCO, Sept. 15 /PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced today that two abstracts on the company's Phase 2 trials of VIA-2291 in patients with acute coronary syndrome (ACS) and in patients undergoing carotid endarterectomy (CEA) surgery, have been accepted for presentation at the American Heart Association (AHA) Scientific Sessions 2008, taking place November 8-12 in New Orleans, LA.

Given AHA's embargo policy, the company will announce the proof of concept data from its CEA and ACS trials concurrent with the AHA sessions.

The presentation details are as follows:

Date/Time: Sunday, November 9, 2008: 5:45 p.m. CDT

Location: Ernest N. Morial Convention Center, Room 275-277

Session: Cardiovascular Seminar: Translational Trials and Strategies:

First in Man

Title: Three Months of Treatment with 5- Lipoxygenase Inhibitor VIA-2291

in Patients with Recent Acute Coronary Syndrome

Presented by: Jean-Claude Tardif, M.D., Professor and Director, Montreal

Heart Institute, Montreal, Canada

Date/Time: Sunday, November 9, 2008: 6:00 p.m. CDT

Location: Ernest N. Morial Convention Center, Room 275-277

Session: Cardiovascular Seminar: Translational Trials and Strategies:

First in Man

Title: Three Months of Treatment with 5-Lipoxygenase Inhibitor VIA- 2291

in Patients Scheduled for Elective Carotid Endarterectomy Surgery

Presented b
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Northstar Global ... that after months of hard work from many ... new Snorenz formulation and package design.  The new ... B-6 back into the product due to overwhelming ... lasting effects.  Snorenz Nighttime will also include these ...
(Date:8/20/2014)... Md. , Aug. 20, 2014  The ... lauded the latest results achieved by the real-time, ... as the National Precursor Log Exchange (NPLEx), automatically ... officials track down methamphetamine offenders and make arrests. ... Michigan blocked the sale ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... is available in its catalogue: ... Key Trends and Opportunities to 2017 ... Synopsis The report provides in depth ... Canadian personal accident and health insurance segment, ...
Breaking Medicine Technology:Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 2Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 3Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 4Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 5Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 6Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 7Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 8Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 9Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 10Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 11Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 12Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 13Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 14Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 15Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 16Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 17Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 18Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 19Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 20Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 21Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 22Personal Accident and Health Insurance in Canada, Key Trends and Opportunities to 2017 23
(Date:8/21/2014)... New York (PRWEB) August 21, 2014 ... Cannabis Network that a company located in Massachusetts has ... the only marijuana patient verification system in ... welcome this new entity to our growing and compassionate ... our belief that these claims are inaccurate. , ...
(Date:8/21/2014)... Steven Reinberg HealthDay Reporter ... experimental drug shows promise in treating respiratory syncytial virus (RSV), ... "We are finally making major progress in being able to ... of serious viral pneumonia, second only to influenza virus," said ... the University of Tennessee College of Medicine in Memphis. ...
(Date:8/21/2014)... do not protest being overcompensated, even when there ... Brains and Behavior Program have found. , This ... previously believed about the inequity of others, researchers ... Brain Connectivity . These findings suggest humans, ... indicating the interest humans show in others, outcomes ...
(Date:8/21/2014)... August 21, 2014 Competing in the ... Metal Greg” will screen on Monday, August 25th at ... International Film Festival. This festival is named in top ... Video Symphony, Sony Software, Avid, and Write Brothers. , ... 12 & LFX, located at 410 South Myrtle Avenue ...
(Date:8/21/2014)... The report "Indoor Location Market by ... Navigation, Location based analytics, Location based services, ... Forecasts and Analysis (2014 - 2019)" defines ... various sub-segments with an in-depth analysis and ... the factors driving this market, various restraints, ...
Breaking Medicine News(10 mins):Health News:MarijuanaDoctors.com Responds to Massachusetts Company's Claim 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 3Health News:Influenced by self-interest, humans less concerned about inequity to others 2Health News:Influenced by self-interest, humans less concerned about inequity to others 3Health News:“Heavy Metal Greg,” a Music Talk Show by Gregory Graham, Will Screen at Action on Film International Film Festival on 08/25/2014 2Health News:Indoor Location Market Worth $3.9 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Indoor Location Market Worth $3.9 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Indoor Location Market Worth $3.9 Billion by 2019 - New Report by MarketsandMarkets 4
... Carolina-based Oaks,Development Group announced today the company has closed ... Drive behind St. David Medical Center in Austin,Texas. A ... is being converted to Oaks, unique tenant-ownership model., ... purpose limited liability,company (L.L.C.). Tenant partners split ownership interest ...
... Blue Cross and Blue,Shield in Wisconsin announced today ... this year. The changes will include reimbursement,modifications and ... by the Centers for Medicare and Medicaid Services ... will help protect,Anthem,s nearly 1 million members from ...
... As part of the Opening Ceremonies of its 37th ... Anatole Hotel, the American Association for Dental Research (AADR) ... , The AADR Distinguished Scientist Award , ... who has contributed outstanding research of particular significance in ...
... 2008 /Xinhua-PRNewswire-FirstCall/ -- China,Shenghuo Pharmaceutical Holdings, Inc. (Amex: ... is engaged in the research, development, manufacture,and marketing ... People,s Republic of China ("PRC"), today announced that ... & Co. Mainland China,Investor Tour to be held ...
... Global,Health, Inc. (OTC Bulletin Board: FGHH) today stated that ... it provided a 2008,revenue forecast of approximately $6.2 million. ... expects 2008 gross margins of 61 percent., A ... Flagship Global Health,s website, http://www.flagshipglobalhealth.com, no later,than ...
... Maker of Rugged Computers Donates GoBook(R) XR-1 Notebooks to ... Support Zambezi ... General Dynamics,Itronix, an industry leading maker of rugged notebook computers, ... Fighting Malaria on the "River of Life." The XR-1 computers ...
Cached Medicine News:Health News:Oaks Development Group Acquires Medical Office Building in Austin, Texas 2Health News:Anthem Blue Cross and Blue Shield in Wisconsin Announces Initiative Aimed at Preventing Serious Medical Errors; Company Committed to Protecting Members' Health and Finances by Not Reimbursing Major Preventable Adverse Events 2Health News:Anthem Blue Cross and Blue Shield in Wisconsin Announces Initiative Aimed at Preventing Serious Medical Errors; Company Committed to Protecting Members' Health and Finances by Not Reimbursing Major Preventable Adverse Events 3Health News:AADR to present prestigious awards and recognitions 2Health News:AADR to present prestigious awards and recognitions 3Health News:China Shenghuo Pharmaceutical Holdings, Inc. to Present at Brean Murray Carret & Co. Mainland China Investor Tour 2Health News:Flagship Global Health Provides 2008 Financial Guidance 2Health News:General Dynamics Itronix Donates Computers to Humanitarian Expedition Fighting Malaria in Africa 2Health News:General Dynamics Itronix Donates Computers to Humanitarian Expedition Fighting Malaria in Africa 3
Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...
... Accutrol is similar in design to the ... incorporates a temperature probe at the tip ... can accurately determine the patient's core body ... accuracy comparable to a pulmonary artery catheter ...
... Ultra Micro Shafts For Insertion Through ... For Light-Weight ... ,Curved Shafts For A More Comfortable Approach., ... ,Protective Cap Supplied For Protection Of Jaws ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
Medicine Products: